Authors
Latest:
What Keeps You Up at Night?Our new department focuses on the issues that the industry faces as it is held to very high standards of compliance with minimal guidance. So what are the rules to be in compliance?
Latest:
Impact of Insulin Delivery Systems in Elderly Patients With Type 2 DiabetesThis real-world study suggests that improved clinical outcomes are possible in the difficult-to-treat elderly patients with type 2 diabetes group without affecting healthcare costs, by initiating insulin therapy with a pen device.
Latest:
The Evolution of Pneumococcal Vaccines and Current GuidelinesPharmacists are in an excellent position to educate and counsel patients on current recommendations.
Latest:
Using the Patient Care Process in the Community: Patient-Oriented CareCommunity pharmacists are valuable health care providers given their accessibility and distribution throughout the community, extended hours of operation, and clinical knowledge.
Latest:
Prevention of Shingles: The Zostavax VaccineDr. Patel is a clinical assistant professor in the Department of Pharmacy Practice, Oregon State University/ Oregon Health & Science University, College of Pharmacy, Portland campus.
Latest:
The Importance of Outcomes in High Cost Drug TherapiesPharmaceutical manufacturers historicially reaped the benefits of operating independently in pricing and discounting drugs based on volume sold in the United States.
Latest:
Exploring the History and Rise of Data Opportunity SystemsThe opportunity to leverage patient immunization history and data at the point of care in a pharmacy environment can increase the trust and credibility of the pharmacist as a member of the patient’s health care team.
Latest:
Quality Initiatives: Pharmacists in the ForefrontPharmacists can lead quality transformation within their organizations.
Latest:
Renin Antagonists: An Alternative to Controlling HypertensionIdentification of aliskiren's role in the management of hypertension has been the focus of several clinical trials which have demonstrated its effectiveness in blood pressure reduction with few side effects.
Latest:
Not Just Dispensing: The Unique Role of Pharmacists in an Outpatient Research PharmacyPharmacists can serve as essential members of a research team in a role that involves much more than traditional dispensing functions.
Latest:
The Role of PARP Inhibitors in Treating Ovarian CancerRucaparib is FDA approved in patients with a BRCA mutation and who have received 2 more prior lines of previous chemotherapy.
Latest:
The Opportunities and Challenges of Specialty DistributionThe distribution of infusible specialty medications comes with difficulties that must be addressed by pharmacies and payers.
Latest:
Influenza Vaccinations During the COVID-19 PandemicGiven the collision of COVID-19 and flu season, receiving the flu vaccine may hold additional benefits by reducing symptoms that may be confused with those of the novel coronavirus.
Latest:
Emergency Preparedness: When Disaster StrikesFor patients who require life-sustaining medications, emergency preparedness is essential. Here is a game plan to guide you and your patients when facing the unexpected.
Latest:
Impact of Co-Payment Discounts on Antidepressant Medication Adherence and CostsA unique co-payment discount program for antidepressants was associated with higher antidepressant medication adherence, lower likelihood of discontinuation, and lower healthcare costs.
Latest:
Optimization of BiopharmaceuticalsPharmacists should be knowledgeable about the different approaches used to modify biopharmaceuticals and how they affect stability, dosing, safety, and efficacy.
Latest:
CAR-NK Cell Immunotherapy Demonstrates Potential for Treating Patients With Relapsed or Refractory LymphomasPatients with relapsed/refractory leukemia and lymphomas generally have a grim prognosis, which has paved the way for immunotherapy treatments.
Latest:
US Cost-Effectiveness of Saxagliptin in Type 2 Diabetes MellitusSaxagliptin, in combination with metformin, provides a durable, well-tolerated, and cost-effective treatment option for patients with type 2 diabetes mellitus, from a US payer perspective.
